Author: Brigitte Schulz-Ratei (1)
Ghrelin Serum Concentrations Are Associated with Treatment Response During Lithium Augmentation of Antidepressants.Int J Neuropsychopharmacol 2017 Sep;20(9):692-697Roland Ricken, Sandra Bopp, Peter Schlattmann, Hubertus Himmerich, Tom Bschor, Christoph Richter, Samuel Elstner, Thomas J Stamm, Brigitte Schulz-Ratei, Alexandra Lingesleben, Friedel M Reischies, Philipp Sterzer, Stefan Borgwardt, Michael Bauer, Andreas Heinz, Rainer Hellweg, Undine E Lang, Mazda Adli
Lithium augmentation of antidepressants is an effective strategy in treatment-resistant depression. The proteohormone ghrelin is thought to be involved in the pathophysiology of depression. The purpose of this study was to investigate the association of treatment response with the course of ghrelin levels during lithium augmentation.
View Full Text PDF Listings View primary source full text article PDFs.